Monthly Archives: May 2008

The DTC Hearings: Gleaning Some Nuggets

By Patrick Clinton | Published: May 13, 2008
Last week’s congressional hearings on direct-to-consumer advertising were, as expected, pretty inconclusive—but that doesn’t mean we won’t be hearing a lot more on the topic. The big question, I think, is when (and whether) the debate will ever get to the point of realism about what DTC is and can be. The idea of advertising [...]
Posted in Advertising | 2 Comments

Scientists Without Borders

By Joanna Breitstein | Published: May 13, 2008
The New York Academy of Sciences held its kickoff last night of Scientists Without Borders. “It’s a Match.com for organizations and resources focused on helping the developing world,” said NYAS president Ellis Rubinstein. The initiative so far consists of a just-launched wiki—and, as such, leaves a little to be desired in terms of content. But the [...]
Posted in R&D, Strategy, Technology | Leave a comment

Valeant to Lay Off Half Its Workforce

By Patrick Clinton | Published: May 6, 2008
The last time Pharm Exec covered Valeant Pharmaceuticals, it was in 2005, and things were looking good for the company. It had a new name, and a sleek new organization, lighter than the old by 8,000 employees. New CEO Timothy Tyson had created a talented and enthusiastic new management team. A new strategy was in [...]
Posted in Strategy | Leave a comment

Merck’s Cordaptive: A Nasty Surprise

By Walter Armstrong | Published: May 1, 2008
If there’s one piece of pharma news that should come as no surprise, it’s FDA throwing a new drug back at its maker with a “Try again later.” After all, the agency spent last year handing out “approvable” letters like pharma hands out freebies. That’s why we’re surprised that analysts, reporters, and possibly [...]
Posted in People, R&D, Regulatory | Leave a comment